# GSK-Challenge-Analysis-of-a-new-cancer-treatment-drug
The project focused on evaluating the effectiveness of a new drug compared to the standard care in shrinking solid tumors in patients who do not respond to other treatments and identify patient subgroups that benefit more from the treatment. 

Please note that due to ethics and privacy, ‘Miraculon-B’ is only used to refer to the name of a drug being developed.
